Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

MCK stock hub

MCK trades against a final fair-value range of $737.34-$1,307.92, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

Read full analysis Valuation Archive

Fair value midpoint

$1016

$737 - $1308

Upside to midpoint

+40.1%

Based on latest report

Confidence

79/100

Data quality and model convergence

Market cap

$87.2B

NYSE

Our take

Research highlights

What our analysis says

Pulled from the latest published report. The full reasoning lives under /analysis.

Biggest opportunity

Bull case

Bull: Expansion into higher-margin specialty and oncology services successfully transforms the revenue mix. Operating margins expand, and steady cash flows fuel aggressive buybacks, pushing value to the $1,308 high.

Biggest risk

Major Retail Network Loss

Recommended action

Strong Buy

MCK is rated Strong Buy at $725.17 versus the reconciled fair value midpoint of $1,016.12, implying +40.12% upside/downside. Confidence is separately disclosed at 79/100.

Market data

Live price

Current market quote for this ticker.

Current price

MCK

In the news

Latest news · MCK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Analysis map

Jump into the research surface

These links all point into /analysis/*, so a hub rollback leaves the report reader and legacy redirects live.

Forecast

Targets

Bull, base, and bear cases with expected-return framing.

Valuation

Models

Fair-value bridge, DCF, owner earnings, and peer multiples.

Sensitivity

Grid

Cost-of-equity and terminal-growth stress table.

Risks

Bear case

Kill scenarios, soft-pass flags, and downside catalysts.

Earnings

Decision tree

Next earnings setup and beat / inline / miss thresholds.

Position sizing

Checkpoints

Entry, exit, conviction, and quarterly monitoring rules.

Financials

History

Revenue, margins, cash flow, and balance-sheet context.

Peers

Comps

Relative valuation and profitability against the cohort.

Moat

Durability

Economic-profit evidence and competitive advantage risk.

Industry cycle

Context

Sector phase, capital cycle, and secular tailwinds.

Scorecard

Factors

Six-factor overlay and 9-category weighted scorecard.

Recommendation

Verdict

Final action, action steps, opportunity, and biggest risk.

Perspectives

Lenses

Growth, value, and income investor reads.

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.4

P25 12.3P50 18.4P75 33.1

Trailing P/E0

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC106.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Our take

Indicator catalog

All MCK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

274

Groups with data

Currency

USD

Showing 274 of 274 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000927653
Company name	McKesson Corporation
Country	United States
Country code	US
Cusip	58155Q103
Employees	51,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	$93.1B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Medical Distribution
Isin	US58155Q1031
Last refreshed	2026-05-10
Market cap	$88.5B
Market cap category	Large-Cap
Price	$736
Price currency	USD
Rev Per Employee	7,910,392.16x
Sector	Healthcare
Sic	5122
Symbol	MCK
Tags	pharmaceuticals
Website	https://www.mckesson.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.38%
EV Earnings	19.55x
EV Sales Forward	0.21x
EV/EBIT	15.11x
EV/EBITDA	13.51x
EV/FCF	16.28x
EV/Sales	0.23x
FCF yield	6.46%
Forward P/E	16.64x
P/E ratio	19.18x
P/S ratio	0.22x
PE Ratio10 Y	60.64x
PE Ratio3 Y	23.06x
PE Ratio5 Y	24.04x
PEG ratio	1.21x
PS Forward	0.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.53%
EBITDA Margin	1.71%
FCF margin	1.42%
Gross margin	3.6%
Gross Profit	$14.5B
Gross Profit Growth	13.31%
Gross Profit Growth Q	24.13%
Gross Profit Growth3 Y	5.91%
Gross Profit Growth5 Y	3.95%
Net Income	$4.8B
Net Income Growth	44.52%
Net Income Growth Q	33.49%
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Net Income Growth3 Y	10.18%
Pretax Margin	1.54%
Profit Margin	1.18%
Profit Per Employee	$93,373
Profitable Years	5
ROA	4.89
Roa5y	4.39
ROCE	40.27
ROIC	106.9
Roic5y	294.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	16.76%
Cagr15y	16.56%
Cagr1y	2.3%
Cagr20y	15.39%
Cagr3y	26.82%
Cagr5y	30.82%
Div CAGR10	11.34%
Div CAGR3	14.94%
Div CAGR5	14.32%
EPS Growth	49.22
EPS Growth Q	37.03
EPS Growth Quarters	3
EPS Growth Years	2
EPS Growth3 Y	15.32
FCF Growth	3.08%
FCF Growth Q	-54.86%
FCF Growth3 Y	6.24%
FCF Growth5 Y	6.93%
OCF Growth	1.15%
OCF Growth Q	-55.85%
OCF Growth10 Y	5.3%
OCF Growth3 Y	6.06%
OCF Growth5 Y	6.27%
Revenue Growth	12.36x
Revenue Growth Q	6.03x
Revenue Growth Quarters	23x
Revenue Growth Years	13x
Revenue Growth3 Y	13.39x
Revenue Growth5 Y	11.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$5.12
Assets	$82.3B
Cash	$4B
Current Assets	$57.2B
Current Liabilities	$67B
Debt	$8.6B
Debt EBITDA	$1.16
Debt FCF	$1.51
Equity	$-834M
Interest Coverage	24.95
Liabilities	$83.2B
Long Term Assets	$25.1B
Long Term Liabilities	$16.1B
Net Cash	$-4.6B
Net Cash By Market Cap	$-5.24
Net Debt EBITDA	$0.67
Net Debt FCF	$0.81
Tangible Book Value	$-17.6B
Tangible Book Value Per Share	$-146
WACC	5.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.85
Inventory Turnover	16.48
Net Working Capital	$-12.2B
Quick ratio	0.48
Working Capital	$-9.8B
Working Capital Turnover	$-50.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.12%
Dividend Growth	15.49%
Dividend Growth Years	18%
Dividend per share	$3.28
Dividend Years	33
Dividend Yield	0.45%
Ex Div Date	2026-06-01
Last Dividend	$0.82
Payout Frequency	Quarterly
Payout Ratio	8.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	370.76%
1Y total return	2.3%
200-day SMA	814.2
3Y total return	104.02%
50-day SMA	874.6
50-day SMA vs 200-day SMA	50over200
5Y total return	283.12%
All Time High	999
All Time High Change	-26.32%
All Time High Date	2026-03-03
All Time Low	15.06
All Time Low Change	4,786.74%
All Time Low Date	1994-12-09
ATR	23.28
Beta	0.36
Beta1y	0.06
Beta2y	0.23
Ch YTD	-10.26
High	772.4
High52	999
High52 Date	2026-03-03
High52ch	-26.32%
Low	726
Low52	637
Low52 Date	2025-08-12
Low52ch	15.56%
Ma50ch	-15.84%
Premarket Change Percent	-2.62
Premarket Price	$735
Premarket Volume	29,128
Price vs 200-day SMA	-9.59%
RSI	19.65
RSI Monthly	52.76
RSI Weekly	36.32
Sharpe ratio	0.08x
Sortino ratio	0.35
Total Return	3.57%
Tr YTD	-10.19
Tr15y	895.57%
Tr1m	-14.07%
Tr1w	-9.57%
Tr3m	-22.34%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	14
Analyst Count Top	3
Analyst Price Target Top	$989
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$11.57
Earnings EPS Estimate Growth	14.33
Earnings Revenue Estimate	101,491,073,752x
Earnings Revenue Estimate Growth	11.75x
Operating Income	$6.2B
Operating Income Growth	25.39
Operating Income Growth Q	66.62
Operating Income Growth3 Y	12.62
Operating Income Growth5 Y	14.18
Operating margin	1.53
Price target	$942
Price Target Change	$27.97
Price Target Change Top	$34.31

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	120,041,849%
Float Percent	99.87%
Net Borrowing	783,000,000
Shares Insiders	0.03%
Shares Institutions	92.32%
Shares Out	120,204,051
Shares Qo Q	-0.81%
Shares Yo Y	-3.12%
Short Float	2.15%
Short Ratio	3.34
Short Shares	2.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$5.7B
Average Volume	1,001,848.9x
Bv Per Share	-18.1
CAPEX	$-436M
Ch10y	335.9
Ch15y	789.6
Ch1m	-14.07
Ch1w	-9.57
Ch1y	1.9
Ch20y	1,405.9
Ch3m	-22.41
Ch3y	101.2
Ch5y	272.5
Ch6m	-13.6
Change	-2.47%
Change From Open	-0.49
Close	754.8
Days Gap	-1.99
Depreciation Amortization	729,000,000
Dollar Volume	1,604,330,237.7
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$6.2B
EBITDA	$6.9B
EPS	$38.38
F Score	6
FCF	$5.7B
FCF EV Yield	6.14x
FCF Per Share	$47.58
Financing CF	-4,631,000,000
Fiscal Year End	March
Founded	1,833
Goodwill	11,316,000,000
Income Tax	$1.1B
Investing CF	-3,432,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	1998-01-05
Last Split Type	Forward
Last10k Filing Date	2026-05-08
Lynch Fair Value	$391
Lynch Upside	-46.91
Ma150	851.4
Ma150ch	-13.54%
Ma20	823.9
Ma20ch	-10.66%
Net CF	-1,888,000,000
Next Earnings Date	2026-08-05
Open	739.8
Optionable	Yes
P FCF Ratio	15.47
P OCF Ratio	14.38
Payment Date	2026-07-01
Position In Range	21.7
Post Close	736.1
Postmarket Change Percent	0.22
Postmarket Price	$738
Ppne	4,726,000,000
Pre Close	754.8
Price Date	2026-05-08
Price EBITDA	$12.84
Relative Volume	2.18x
Revenue	403,430,000,000x
Tax By Revenue	0.27x
Tax Rate	17.77%
Tr20y	1,651.79%
Tr6m	-13.45%
Us State	Texas
Volume	2,179,530
Z Score	6.08

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

9/10

Business quality stays separate from stock attractiveness.

Forward P/E

14.4x

Valuation uses the full report model stack, not a single multiple.

Next action

Strong Buy

Final action steps are kept in the recommendation tab.

Our take

Income

MCK dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$3.28 annual per share

Payout ratio

+8.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+14.3%

18 consecutive years of growth

Total shareholder yield

+3.6%

Next ex-dividend date: 2026-06-01

Performance

MCK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MCK?

Insider, institutional, and short-interest positioning.

Institutional ownership

+92.3%

Float: +99.9% of shares outstanding

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MCK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

19.6

Below 30: short-term oversold

Price vs 200-day MA

-9.6%

50/200-day relationship not available

Beta (5Y)

0.36

Less volatile than the market

Sharpe ratio

0.08

Risk-adjusted return — higher is better; >1.0 is solid.

Peers

MCK vs. sector cohort

Currency-neutral comparison: P/E, P/S, ROIC, 5Y revenue CAGR, and 1Y total return. Market-cap column appears only when every peer reports in the same currency.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	4.3T	35.6x	9.5x	104.3%	+6.8%	+50.1%	매도
ABNB	Airbnb Inc.	84B	34.7x	6.6x	15.9%	+29.9%	+14.9%	보유
ADBE	Adobe Inc.	102.3B	14.8x	4.2x	63.3%	+12.3%	-34.3%	적극 매수

Questions

About MCK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MCK stock rating?

McKesson Corporation is currently shown with Strong Buy in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MCK analysis?

The full report lives at /stocks/MCK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MCK?

The latest report frames MCK around $737 to $1308. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MCK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.